Katherine R. Tuttle, MD, FASN, FACP, FNKF is Executive Director for Research at Providence Inland Northwest Health, Regional Principal Investigator of the Institute of Translational Health Sciences and Professor of Medicine at the University of Washington. Dr. Tuttle’s major research interests are in diabetes and chronic kidney with over 350 original peer-reviewed publications. She leads the Center for Kidney Disease Research, Education and Hope (CURE-CKD) Registry of real-world data for chronic kidney disease, diabetes, prediabetes, and hypertension from over 5 million health system patients. Dr. Tuttle is also Chair of the Diabetic Kidney Disease Collaborative for the American Society of Nephrology.

Anthony Good, DNP, MSN, MBA, APRN, FNP-BC, GNP-BC, RN joined the faculty at St. Francis in 2021 as the Program Director, MSN Family (Individual Across the Lifespan) Nurse Practitioner and Program Director Family (Individual Across the Lifespan) Post-Master’s Certificate. He has practiced as a nurse practitioner in primary care, urgent care and nephrology. He continues to maintain active practice at Advanced Kidney Care Medical Associates, Pittsburgh, Pennsylvania. He has been a faculty member for more than 10 years and his research interests include simulation, quality of life and care satisfaction.

Joshua J. Neumiller, PharmD, CDCES, FASCP, FADCES is the Allen I. White Distinguished Professor in the College of Pharmacy and Pharmaceutical Sciences at Washington State University (WSU). He served as Chair of the ADA’s (American Diabetes Association) Professional Practice Committee from 2018-2019, whose primary responsibility is updating the ADA’s Standards of Care in Diabetes each year. Josh is currently President Elect for Health Care & Education at ADA and is co-Editor for the ADA’s Guide to Medications for the Treatment of Diabetes Mellitus. In addition to his work at WSU, Josh holds a research appointment with Providence Medical Research Center in Spokane, Washington and is an investigator with the Center for Kidney Disease Research, Education and Hope (CURE-CKD).

Mikhail Kosiborod, MD is a Cardiologist, Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City. Dr. Kosiborod is an internationally recognized expert in the fields of diabetes and cardiovascular disease, cardiometabolic and cardiorenal syndromes as well as quality of care and outcomes. He has authored and co-authored over 220 peer reviewed publications, including scientific statements and position documents. He is involved in the leadership of multiple clinical trials and multi-center registries and is currently the principal investigator of several investigator-initiated, multicenter trials in diabetes and CVD.

Prakash Deedwania, MD, FACC, FAHA, FESC is one of the most recognizable figures in the fields of diabetes, hypertension, heart failure, lipid disorders, ischemic heart disease, rhythm disorders and preventive cardiology where he has authored numerous landmark clinical trials and several clinical practice guidelines. He is a respected leader of several national and international medical societies, having held various positions at the AHA, the American College of Cardiology and the National Health Lung & Blood Institute. He has published over a thousand medical manuscripts, and is on the editorial board of the top medical journals including the Journal of the American College of Cardiology, American Journal of Cardiology, Clinical Cardiology, among many others.

Suzanne V. Arnold, MD, MHA is an Associate Professor of Medicine at the University of Missouri-Kansas City and a cardiologist at Saint Luke’s Mid America Heart Institute. She also completed a cardiovascular outcomes research fellowship through the AHA. Her research centers on the long-term outcomes of patients with CVD, with a particular focus on patients’ quality of life—how to best assess it, what factors influence it and how to improve it. She was the recipient of several research awards, including the Burton Sobel Award for Excellence in Cardiovascular Research at Washington University in St. Louis and the AHA Young Investigator Award.

Dr. Nancy M. Albert is Associate Chief Nursing Officer—Nursing Research and Innovation, Cleveland Clinic health system and a Clinical Nurse Specialist in heart failure—Kaufman Center for Heart Failure, Heart, Vascular and Thoracic Institute, Cleveland Clinic. Dr. Albert is a leader, Research Scientist, advanced Practice Nurse in a heart failure clinic, Consultant and Educator. She has 340 peer reviewed health care journal publications, over 18 book chapters and she is editor of 2016 book, Building and Sustaining a Hospital-Based Nursing Research Program. Dr. Albert volunteers for many health care organizations and presents locally, nationally and internationally on cardiovascular (heart failure), research and innovation themes.

Dr. Mikhail Kosiborod is a Cardiologist, Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City. Dr. Kosiborod is an internationally recognized expert in the fields of diabetes and CVD, cardiometabolic and cardiorenal syndromes as well as quality of care and outcomes. He has authored and co-authored over 220 peer reviewed publications, including scientific statements and position documents. He is involved in the leadership of multiple clinical trials and multi-center registries and is currently the principal investigator of several investigator-initiated, multicenter trials in diabetes and CVD.

Shannon Dunlay, MD, MS is a is an Advanced Heart Failure Cardiologist and Associate Professor of Medicine and Health Services Research at the Mayo Clinic in Rochester, Minnesota. Her research focuses on examining factors that impact health care utilization and outcomes in patients with heart failure. Clinically, she cares for patients with advanced heart failure, including those that require mechanical circulatory support and cardiac transplantation. She has been an active member of the American Heart Association where she serves on several committees and is an Associate Editor at Circulation: Cardiovascular Quality and Outcomes.